149 related articles for article (PubMed ID: 3544821)
1. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.
Greenberg A; Egel JW; Thompson ME; Hardesty RL; Griffith BP; Bahnson HT; Bernstein RL; Hastillo A; Hess ML; Puschett JB
Am J Kidney Dis; 1987 Jan; 9(1):12-22. PubMed ID: 3544821
[TBL] [Abstract][Full Text] [Related]
2. The effect of cyclosporine on early graft function in human renal transplantation.
Flechner SM; Payne WD; Van Buren C; Kerman R; Kahan BD
Transplantation; 1983 Sep; 36(3):268-72. PubMed ID: 6351368
[TBL] [Abstract][Full Text] [Related]
3. Respiratory complications of cardiac transplantation.
Schulman LL; Smith CR; Drusin R; Rose EA; Enson Y; Reemtsma K
Am J Med Sci; 1988 Jul; 296(1):1-10. PubMed ID: 3044104
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
[TBL] [Abstract][Full Text] [Related]
6. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
7. Serum potassium concentrations in cyclosporine- and azathioprine-treated renal transplant patients.
Foley RJ; Hamner RW; Weinman EJ
Nephron; 1985; 40(3):280-5. PubMed ID: 3892345
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplantation.
Powell-Jackson PR; Young B; Calne RY; Williams R
Transplantation; 1983 Nov; 36(5):505-8. PubMed ID: 6356514
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.
Wilkinson AH; Smith JL; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
Transplantation; 1989 Feb; 47(2):293-6. PubMed ID: 2645716
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in cardiac transplantation.
Devineni R; McKenzie N; Keown P; Kostuk W; Stiller C; Silver M
Can J Surg; 1984 May; 27(3):252-4. PubMed ID: 6232993
[TBL] [Abstract][Full Text] [Related]
11. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
Knight RJ; Kerman RH; Welsh M; Golden D; Schoenberg L; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1991 Feb; 51(2):355-9. PubMed ID: 1994527
[TBL] [Abstract][Full Text] [Related]
12. Kidney function in heart-lung transplant recipients: the effect of low-dosage cyclosporine therapy.
Imoto EM; Glanville AR; Baldwin JC; Theodore J
J Heart Transplant; 1987; 6(4):204-13. PubMed ID: 3117987
[TBL] [Abstract][Full Text] [Related]
13. [The effect of cyclosporin on renal function following cardiac transplantation: should one lessen the toxicity?].
Carrier M; Pelletier GB; Leclerc Y; Castonguay YR; Solymoss BC; Pelletier LC
Can J Surg; 1990 Jun; 33(3):243-7. PubMed ID: 2350751
[TBL] [Abstract][Full Text] [Related]
14. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.
Moyer TP; Post GR; Sterioff S; Anderson CF
Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
[No Abstract] [Full Text] [Related]
17. [Kaposi's sarcoma in kidney transplant treated with cyclosporin and azathioprine].
Cózar JM; Martínez Piñeiro L; Avellana JA; de la Peña J; Hidalgo L; Sanz A; Burgos F; Martínez Piñeiro JA
Arch Esp Urol; 1990 Mar; 43(2):155-8. PubMed ID: 2363579
[TBL] [Abstract][Full Text] [Related]
18. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
[TBL] [Abstract][Full Text] [Related]
19. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
Lough ME; Miller JL; Gamberg P
J Heart Transplant; 1986; 5(4):322-6. PubMed ID: 3305825
[TBL] [Abstract][Full Text] [Related]
20. Increased serum beta 2 microglobulin during rejection, cyclosporine-induced nephrotoxicity, and cytomegalovirus infection in renal transplant recipients.
Bäckman L; Ringdén O; Björkhem I; Lindbäck B
Transplantation; 1986 Oct; 42(4):368-71. PubMed ID: 3020748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
